法规动态

FDA、EMA、TGA 及全球法规动态

#transdermal patch ×

2026年9月10日•1 分钟阅读

FDA Approves TRANSDERM SCOP (NDA017874) Transdermal Scopolamine Patch

The FDA has approved the prescription transdermal patch TRANSDERM SCOP, containing 1 mg scopolamine per 72 hr, under NDA 017874. Baxter Healthcare is the manufacturer.

2026年9月3日•1 分钟阅读

FDA Approves ANDA210272 for Buprenorphine Transdermal Patch

The FDA has approved application ANDA210272 for a buprenorphine transdermal patch, covering five dosage strengths and requiring a REMS program.